Is LSA (Morning Glory) legal in New Zealand?

Legal status

LSA (ergine, d-lysergic acid amide) is caught as a controlled drug analogue under the Misuse of Drugs Act 1975: it falls within the statutory "controlled drug analogue" definition (a substance with a structure substantially similar to that of a controlled drug, here lysergide/LSD), which makes it a Class C controlled drug by operation of the Act. The compound is reached by the analogue provision, while the morning-glory and Hawaiian baby woodrose plants and their seeds are not scheduled and stay legal to possess, cultivate and sell.

Consequences if caught

Dealing with the analogue LSA/ergine is a Class C offence — possession up to 3 months and supply up to 8 years' imprisonment; cultivating or holding the seeds and plants themselves is lawful, so enforcement turns on the extracted or prepared LSA rather than the ornamental seed.

If prescribed or medical

No therapeutic or prescription status; as a controlled drug analogue LSA is treated as Class C with no approved medical use.

Documentation

Misuse of Drugs Act 1975, s2 "controlled drug analogue" definition (Part 7 of Schedule 3) — the analogue mechanism captures ergine/LSA as an LSD analogue, while the seed-bearing plants remain unscheduled.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with New Zealand’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.